Sign in to follow this  
Followers 0
Jeannie McClelland

Differences in presentation of younger and older systemic sclerosis (SSc) patients in clinical trials

1 post in this topic

Differences in presentation of younger and older systemic sclerosis (SSc) patients in clinical trials. After adjustment for population norms and potential confounders, including medications, only differences in alkaline phosphatise and CK (muscle enzymes) remain between younger and older patients with SSc. Overall, older patients with SSc in clinical trials seem to be more similar to younger patients than was previously thought. Weng HH. (PubMed) Clin Exp Rheumatol. 2010 Sep-Oct;28(5 Suppl 62):S10-4. (Also see: Clinical Trials)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jeannie McClelland

(Retired) ISN Director of Support Services

(Retired) ISN Sclero Forums Manager

(Retired) ISN Blog Manager

(Retired) ISN Assistant News Guide

(Retired) ISN Artist

International Scleroderma Network

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!


Register a new account

Sign in

Already have an account? Sign in here.


Sign In Now
Sign in to follow this  
Followers 0